Skip to content

Clinical trials

Myelodysplastic Syndromes trials in Hungary

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myelodysplastic Syndromes Country / region: Hungary Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20073
20081
20091
20111
20141
20151
20181
20193
20203
20213
20231
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Terminated6
Active, not recruiting3
Recruiting3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals6
Celgene3
Taiho Oncology, Inc.2
Takeda2
AbbVie1
Astex Pharmaceuticals, Inc.1
Bristol-Myers Squibb1
Gamida Cell -Teva Joint Venture Ltd.1
Gilead Sciences1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myelodysplastic Syndromes22
Leukemia, Myeloid, Acute8
Leukemia, Myelomonocytic, Chronic5
Anemia4
Anemia, Refractory, with Excess of Blasts3
Thrombocytopenia2
Hematologic Diseases1
Hematologic Neoplasms1
Hodgkin Disease1
Iron Overload1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.